Themis Medicare Ltd.
Snapshot View

1126.10 +59.90 ▲5.6%

08 December 2022, 04:01:00 PM
Volume: 7,604

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.themismedicare.com
Market Cap 1,034.25 Cr.
Enterprise Value(EV) 1,093.20 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 62.60 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 17.99 Trailing Twelve Months Ending 2022-09
Industry PE 34.64 Trailing Twelve Months Ending 2022-09
Book Value / Share 345.53 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.26 Calculated using Price: 1,126.10
Dividend Yield 0.44 Period Ending 2022-03
No. of Shares Subscribed 0.92 Cr. 9,200,270 Shares
FaceValue 10
Company Profile
Themis Medicare (TML) incorporated in 1969, is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs) and Formulations. Erstwhile known as Themis Chemical the company is promoted by Mr. Shantibhai D. Patel. It is joint venture with Gedeon Richter, Hungary.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+5.62%
1 Week
+10.85%
1 Month
+25.65%
3 Month
+37.35%
6 Month
+45.33%
1 Year
+20.53%
2 Year
+199.26%
5 Year
+105.87%
10 Year
+1049.08%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.00 9.40 22.85 13.16 5.42 -8.00 9.34 13.09 24.35
Return on Capital Employed (%) 9.53 9.45 14.69 12.92 8.52 -1.25 11.81 15.21 27.68
Return on Assets (%) 0.97 1.94 5.52 5.29 2.95 -4.29 4.86 7.32 15.14

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 57 59 74 152 169 158 183 219 287 318
Non Curr. Liab. 90 82 71 8 7 3 8 24 31 29
Curr. Liab. 137 136 130 124 125 147 155 128 124 121
Minority Int. 0 0
Equity & Liab. 284 277 275 284 301 307 345 371 442 467
Non Curr. Assets 149 143 142 160 157 158 165 186 214 229
Curr. Assets 134 133 133 124 143 150 180 185 228 238
Misc. Exp. not W/O
Total Assets 284 277 275 284 301 307 345 371 442 467

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 195 202 232 217 210 184 202 231 395 360
Other Income 5 13 3 3 3 3 3 4 7 9
Total Income 200 214 236 220 213 186 205 234 401 369
Total Expenditure -171 -184 -194 -184 -185 -181 -166 -181 -299 -287
PBIDT 29 31 41 36 28 5 39 53 102 82
Interest -16 -15 -12 -12 -12 -12 -13 -13 -9 -9
Depreciation -9 -11 -12 -7 -7 -8 -8 -9 -9 -10
Taxation -1 1 -2 -2 0 2 -2 -6 -22 -19
Exceptional Items
PAT 3 5 15 15 9 -13 16 26 62 45
Minority Interest 0 0
Share Associate 1 1 1 3 2 9 9 11 13
Other Related Items
Consolidated Net Profit 3 6 16 16 11 -11 25 36 73 58
Adjusted EPS 3 7 19 18 12 -12 27 39 79 63

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 4 8 19 26 -2 8 11 0 57 34
Cash Fr. Inv. -5 -7 -6 -7 -4 0 -4 -5 -16 -16
Cash Fr. Finan. 29 2 -18 -13 5 -9 -10 7 -26 -18
Net Change 29 4 -5 5 0 -1 -3 2 16 1
Cash & Cash Eqvt -38 -35 -40 -34 6 4 2 3 19 20

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 67.27 67.26 67.26 67.22 67.18 67.18 67.18 67.18 67.18
Public 32.73 32.74 32.74 32.78 32.82 32.82 32.82 32.82 32.82
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 23.51 23.51 23.51 23.51 23.51

Announcements View Details >>

Thu, 01 Dec 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (the Listing Regulations) read with part A of Schedule III of the Listing Regulations we wish to inform that the management of the Company did physical meetings with Analysts/Investors on Thursday 1st December 2022; the details of the same are given below:Sr. no. Name Venue1 Counter Cyclical PMS Mumbai2 Enam Holdings Pursuant to regulation 46(2) of the Listing Regulations aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com
Tue, 29 Nov 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (the Listing Regulations) read with part A of Schedule III of the Listing Regulations we wish to inform that the management of the Company will do physical meetings with Analysts/Investors on Thursday 1st December 2022; the details of the same are given below:Sr. no. Name Venue1 Counter Cyclical PMS Mumbai2 Enam Holdings Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company.Pursuant to regulation 46(2) of the Listing Regulations aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com
Mon, 21 Nov 2022
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and with reference to our letter dated 7th November 2022 intimating you about the earning conference call for Q2 & H1 FY23 with Analysts/Investors held on 16th November 2022 please find attached herewith the transcript of the aforesaid conference call.The above information is also available on the website of the Company at https://www.themismedicare.com

Technical Scans View Details >>

Thu, 08 Dec 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Close Within 52 Week High Zone Close Within 52 Week High Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,362.76 980.95 -3.6%
Cipla Ltd. 89,585.15 1,110.00 +0.4%
Divi's Laboratories Ltd. 87,333.85 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. 72,223.59 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. 67,735.51 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. 54,831.55 1,620.10 -0.4%
Abbott India Ltd. 43,044.71 20,257.00 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 57.34 980.95 -3.6%
Cipla Ltd. Consolidated 2022-09 34.91 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 29.18 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.23 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 80.68 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.80 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-09 48.82 20,257.00 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.43 980.95 -3.6%
Cipla Ltd. Consolidated 2022-09 4.09 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-09 7.20 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.48 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.32 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.00 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-09 15.86 20,257.00 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 0.00 20,257.00 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,257.00 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 29.95 20,257.00 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,257.00 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 980.95 -3.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,110.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,289.80 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,337.75 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,710.90 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,620.10 -0.4%
Abbott India Ltd. Standalone 2022-03 798.70 20,257.00 +0.2%

FAQ's On Themis Medicare Ltd.

What is Themis Medicare share price?

Can I buy Themis Medicare shares now?

What is the Dividend Yield of Themis Medicare?

What is the Market Cap of Themis Medicare?

What are the key metrics to analyse Themis Medicare?

What is the 52 Week High and Low of Themis Medicare?

What is the trend of Themis Medicare share price?